Radiation dose-volume effects of the urinary bladder.

An in-depth overview of the normal-tissue radiation tolerance of the urinary bladder is presented. The most informative studies consider whole-organ irradiation. The data on partial-organ/nonuniform irradiation are suspect because the bladder motion is not accounted for, and many studies lack long enough follow-up data. Future studies are needed.

[1]  J. Hanley,et al.  Split‐course radiotherapy of carcinoma of the urinary bladder Stages C and D1: A Radiation Therapy Oncology Group study , 1985, American Journal of Clinical Oncology.

[2]  Christian Kirisits,et al.  Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. , 2005, International journal of radiation oncology, biology, physics.

[3]  W. Duncan,et al.  Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. , 1986, International journal of radiation oncology, biology, physics.

[4]  J. Wondergem,et al.  Hypofractionated radiotherapy for invasive bladder cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  V. Khoo,et al.  Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[6]  S L Schoeppel,et al.  Three-dimensional treatment planning of intracavitary gynecologic implants: analysis of ten cases and implications for dose specification. , 1994, International journal of radiation oncology, biology, physics.

[7]  J. Dimopoulos,et al.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  P. Carroll,et al.  The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. , 1995, International journal of radiation oncology, biology, physics.

[9]  G. Kerr,et al.  An analysis of the radiation related morbidity observed in a randomized trial of neutron therapy for bladder cancer. , 1986, International journal of radiation oncology, biology, physics.

[10]  I. Barillot,et al.  Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  M. Zelefsky,et al.  Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. , 1997, International journal of radiation oncology, biology, physics.

[12]  Phillip M Devlin,et al.  Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. , 2006, International journal of radiation oncology, biology, physics.

[13]  A. Zietman,et al.  Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. , 2002, Urology.

[14]  Patricia J Eifel,et al.  Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. , 2005, International journal of radiation oncology, biology, physics.

[15]  R. Fisher,et al.  The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the prince of Wales hospital, Sydney, Australia , 1992, Cancer.

[16]  D. Bodurka,et al.  Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Richie,et al.  Urological complications of cyclophosphamide. , 1989, The Journal of urology.

[18]  W. Duncan,et al.  The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  R. Cowan,et al.  Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. , 1997, International journal of radiation oncology, biology, physics.

[20]  L. Muren,et al.  Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  J. Dunst,et al.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Cormack,et al.  Final results of a prospective study of MR-based interstitial gynecologic brachytherapy , 2008 .

[23]  C C Ling,et al.  CT-assisted assessment of bladder and rectum dose in gynecological implants. , 1987, International journal of radiation oncology, biology, physics.

[24]  N. Green,et al.  Prostate cancer: post-irradiation incontinence. , 1990, The Journal of urology.

[25]  A. Zietman,et al.  Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer. , 2002, The Journal of urology.

[26]  G. Kerr,et al.  Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer. , 1985, Clinical radiology.

[27]  H. Bartelink,et al.  A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder. , 1997, International journal of radiation oncology, biology, physics.

[28]  P. Wang,et al.  Urinary tract dysfunction after radical hysterectomy for cervical cancer. , 2002, Gynecologic oncology.

[29]  G. Read,et al.  A randomised comparison of photons and 15 MeV neutrons for the treatment of carcinoma of the bladder. , 1985, The British journal of radiology.

[30]  P. Eifel,et al.  Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. , 1999, International journal of radiation oncology, biology, physics.

[31]  L. K. Petersen,et al.  Urodynamic and ultrasound characteristics of incontinence after radical hysterectomy , 2007, Neurourology and urodynamics.

[32]  A. Yavuz,et al.  Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer. , 2003, International journal of radiation oncology, biology, physics.

[33]  D. Dearnaley,et al.  A randomised trial of accelerated radiotherapy for localised invasive bladder cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  Yoshiya Yamada,et al.  Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. , 2008, International journal of radiation oncology, biology, physics.

[35]  A. Hanlon,et al.  Late GI and GU complications in the treatment of prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[36]  Mitchell Morris,et al.  Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  C. Lawton.  Bladder-sparing, Combined-modality Approach for Muscle-invasive Bladder Cancer: A Multi-institutional, Long-term Experience , 2009 .

[38]  Yoshiya Yamada,et al.  Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. , 2008, International journal of radiation oncology, biology, physics.

[39]  Steven Haker,et al.  Deformable structure registration of bladder through surface mapping. , 2006, Medical physics.

[40]  D. Dearnaley,et al.  Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[41]  T. Hellebust,et al.  Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  M. Hoogeman,et al.  Update of the Results of the Dutch Multicenter Dose Escalation Trial of Radiotherapy for Localized Prostate Cancer , 2007 .

[43]  E. Milroy,et al.  Invasive bladder cancer treated by radical external radiotherapy. , 1985, British journal of urology.

[44]  Y. Yamada,et al.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[45]  D. Kuban,et al.  Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[46]  C. Lawton.  Update of Dutch Multicenter Dose-Escalation Trial of Radiotherapy for Localized Prostate Cancer , 2009 .

[47]  A Wambersie,et al.  Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[48]  M. Hulshof,et al.  Concomitant boost radiotherapy for muscle invasive bladder cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[49]  G. A. King,et al.  Bladder carcinoma: Experiences with radical and preoperative radiotherapy in 421 patients , 1984 .

[50]  P. Koper,et al.  Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. , 2005, International journal of radiation oncology, biology, physics.

[51]  L. Muren,et al.  Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. , 2008, International journal of radiation oncology, biology, physics.

[52]  J. Wharton,et al.  Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. , 1995, International journal of radiation oncology, biology, physics.

[53]  J. Elwood,et al.  Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. , 1981, International journal of radiation oncology, biology, physics.

[54]  J. Richie,et al.  Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.